AVIS: The Effect of Vitamin D Supplementation on Glucose Metabolism in Non-Diabetic African American Adults

Sponsor
Augusta University (Other)
Overall Status
Completed
CT.gov ID
NCT01141192
Collaborator
(none)
48
1
2
3.9
12.2

Study Details

Study Description

Brief Summary

Type 2 diabetes is more common among African Americans than Caucasians. African Americans are also at a higher risk for lower levels of vitamin D compared to other ethnic groups. The investigators don't yet know if there is a connection between not having enough vitamin D and type 2 diabetes in African Americans. Researchers have found that the less vitamin D Caucasians had the higher the chance they would have type 2 diabetes but it is less clear if this is the case for African Americans. The investigators want to better understand how vitamin D status and diabetes risk are linked in African Americans. Also, the investigators want to see if supplementation with vitamin D will improve your blood pressure, blood sugar, & insulin. All of these are in some way related to diabetes. The investigators want to measure changes in blood sugar & blood pressure in people who do not have diabetes with the hope of learning new information to help treat those that do have diabetes.

The investigators hypothesize that vitamin D status is related to diabetes risk measured by hemoglobin A1c (a test of glucose level over time), fasting glucose and insulin in non-diabetic African American adults and that body weight status may affect vitamin D status in response to vitamin D supplements compared to placebo.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: vitamin D3, cholecalciferol
  • Dietary Supplement: Inactive comparator
N/A

Detailed Description

Participants will be randomly assigned to receive either a 60,000 IU vitamin D3 supplement every four weeks or an inactive placebo. All investigators and the participants will be blinded to the assignment group of each participant until all testing is completed.

Study Design

Study Type:
Interventional
Actual Enrollment :
48 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Prevention
Official Title:
The Effect of Vitamin D Supplementation on Glucose Metabolism in Non-Diabetic African American Adults
Study Start Date :
Jan 1, 2010
Actual Primary Completion Date :
May 1, 2010
Actual Study Completion Date :
May 1, 2010

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Vitamin D3 supplement

60,000 IU vitamin D3 oral supplement provided every four weeks at weeks 0, 4, 8, and 12 in the form of one 50,000 and two 5,000 IU vitamin D3 supplements in gelcap form.

Dietary Supplement: vitamin D3, cholecalciferol
1 gelcap of 50,000 IU vitamin D3 plus 2 gelcaps of 5,000 IU vitamin D3 each; a total of 60,000 IU vitamin D3 dosed four weeks apart at weeks 0, 4, 8, and 12 of the 16 week study.

Placebo Comparator: Sugar Pill

Inactive placebo tablets identical in appearance to the active comparator provided every four weeks at weeks 0,4,8,and 12.

Dietary Supplement: Inactive comparator
The inactive comparator dose provided was identical in appearance to the active comparator but contained no vitamin D3

Outcome Measures

Primary Outcome Measures

  1. Fasting glucose level before, mid-way through, and after the vitamin D3 supplement or placebo trial. [16 weeks]

Secondary Outcome Measures

  1. Serum 25-OH D levels in response to vitamin D3 supplement or placebo across a range of adiposity [16 weeks]

Eligibility Criteria

Criteria

Ages Eligible for Study:
19 Years to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • African American by self-report

  • In good health

Exclusion Criteria:
  • Diagnosis of diabetes

  • Health problems/medication affecting calcium and/or vitamin D metabolism

  • Current use of vitamin/mineral/herbal/nutritional supplements

  • Inability to swallow pills

  • Pregnancy

Contacts and Locations

Locations

Site City State Country Postal Code
1 Medical College of Georgia Augusta Georgia United States 30912

Sponsors and Collaborators

  • Augusta University

Investigators

  • Study Director: Yanbin Dong, MD, PhD, Augusta University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT01141192
Other Study ID Numbers:
  • 0910091
First Posted:
Jun 10, 2010
Last Update Posted:
Jun 10, 2010
Last Verified:
Jun 1, 2010

Study Results

No Results Posted as of Jun 10, 2010